In a new study published in the journal GeroScience, VAS101 (Vasceptor®), a novel curcumin transdermal formulation developed by Vascarta Inc. (Summit, NJ, USA), when administered topically twice ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback